Don Rockey to Ascites
This is a "connection" page, showing publications Don Rockey has written about Ascites.
Connection Strength
1.678
-
The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites. Am J Med Sci. 2016 Feb; 351(2):169-76.
Score: 0.521
-
Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosis. J Hepatol. 2013 Jun; 58(6):1113-8.
Score: 0.422
-
Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am J Gastroenterol. 2000 Jan; 95(1):199-203.
Score: 0.171
-
Cirrhotic ascites, ovarian carcinoma, and CA-125. South Med J. 1999 Feb; 92(2):248-50.
Score: 0.160
-
Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score. Am J Gastroenterol. 1998 Oct; 93(10):1891-4.
Score: 0.157
-
Complications of cirrhosis. Curr Opin Gastroenterol. 2012 May; 28(3):223-9.
Score: 0.100
-
Complications and outcomes in chronic liver disease. Curr Opin Gastroenterol. 2011 May; 27(3):204-9.
Score: 0.094
-
Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Aliment Pharmacol Ther. 2023 Mar; 57(5):454-463.
Score: 0.053